Real-world data on emicizumab prophylaxis in the Milan cohort.
Haemophilia
; 28(5): e141-e144, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35853212
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Bispecific
/
Hemophilia A
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Haemophilia
Journal subject:
HEMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom